Safa Tahmasebi | Biochemistry | Best Researcher Award | 10070

Dr. Safa Tahmasebi | Biochemistry | Best Researcher Award

PhD of Immunology at Shahid Beheshti University of Medical Sciences | Iran

Dr. Safa Tahmasebi is an accomplished researcher in medical immunology, with expertise in cancer immunotherapy, stem cell biology, exosome research, and immune regulation in infectious and autoimmune diseases. Holding a PhD in Medical Immunology from Shahid Beheshti University of Medical Sciences, she has led and collaborated on numerous impactful projects, including translational research on CAR-T and CAR-NK therapies and novel immunotherapeutic strategies. She has authored multiple publications in high-impact journals indexed in Scopus and PubMed, alongside contributions to books and international congresses where she has delivered invited lectures and top-ranked presentations. Beyond research, she has demonstrated leadership in student research committees, organized academic workshops, and contributed to community platforms. Her achievements reflect strong academic excellence, research innovation, and a commitment to advancing global healthcare through science and education.

Professional Profiles

Google Scholar | Scopus | Orcid

Education

Dr. Safa Tahmasebi has pursued a distinguished academic path in the field of medical sciences, consistently excelling at every stage. She completed her Bachelor’s degree in Laboratory Sciences, achieving first rank throughout her studies. She then earned a Master’s in Medical Immunology, securing top positions in the national entrance examinations, followed by a PhD in Medical Immunology from Shahid Beheshti University of Medical Sciences. During her doctoral studies, she specialized in advanced immunological mechanisms, cancer immunotherapy, and translational medicine, with a strong focus on CAR-T and CAR-NK therapies. Her educational background reflects academic excellence, perseverance, and a deep commitment to scientific advancement. The rigorous training she received has laid a strong foundation for her subsequent professional and research contributions, preparing her to lead innovative projects at both national and international levels.

Experience

Dr. Safa Tahmasebi has gained extensive professional experience as a researcher, educator, and academic leader. She has served as an executive and collaborator in multiple high-impact research projects, including studies on immunotherapy, stem cell applications, exosomes in cancer progression, and immune responses in infectious diseases. Her role extends beyond laboratory research into teaching, where she has conducted theoretical and practical courses in immunology for students in medicine, nursing, pharmacy, and dentistry. She has also organized advanced workshops on systematic reviews, SPSS, ELISA, and cancer immunology, equipping young researchers with essential scientific skills. Additionally, she has been actively involved in student research committees and community platforms, taking leadership roles in guiding scientific initiatives. Through these experiences, she has demonstrated a balance of research innovation, academic mentoring, and community engagement.

Research Interest

Dr. Safa Tahmasebi’s research interests lie at the intersection of immunology, oncology, and translational medicine, with a particular focus on innovative therapeutic strategies. Her primary work involves developing and improving cancer immunotherapies such as CAR-T and CAR-NK cell therapies, investigating tumor microenvironment dynamics, and exploring the roles of exosomes and non-coding RNAs in cancer progression. She is also deeply engaged in studying immune regulation in autoimmune and infectious diseases, including COVID-19, where she has published widely on vaccine responses and immunomodulatory therapies. Her interests extend to anti-aging research, stem cell-based therapies, and the application of artificial intelligence in cancer prediction and treatment. With an emphasis on bridging laboratory research with clinical application, her vision is to advance therapies that significantly improve patient outcomes and contribute to global health solutions.

Awards and Honors

Dr. Safa Tahmasebi has received numerous awards and honors that recognize her academic excellence, research achievements, and community contributions. She has consistently ranked first in national examinations for both her Master’s and PhD programs, highlighting her strong academic foundation. Her achievements include being selected as a model student at both institutional and provincial levels, receiving the National Student Dedication Award for social responsibility, and earning recognition from the National Elite Foundation through multiple Shahid Zazai Projects for top students. She has also been honored as the Outstanding Research Student and selected for the Immunology and Allergy Festival as a leading PhD researcher. These accolades reflect her commitment to scientific excellence, leadership, and service to society, reinforcing her reputation as a highly accomplished and respected young researcher.

Research Skills

Dr. Safa Tahmasebi possesses a comprehensive set of research skills that combine technical expertise with strong analytical and leadership abilities. She is proficient in advanced laboratory techniques such as cell culture, ELISA, flow cytometry, molecular biology methods, and immunological assays. Her expertise extends to systematic reviews, meta-analysis, and the application of statistical tools like SPSS for biomedical research. She has successfully led projects involving experimental models of cancer, immunomodulatory therapies, and exosome-based studies, demonstrating skill in both experimental design and translational application. Additionally, she has significant experience in academic writing, with numerous publications in high-impact journals, books, and conference proceedings. Her ability to lead interdisciplinary projects, collaborate internationally, and mentor students underscores her strengths not only as a researcher but also as an academic leader committed to advancing medical science.

Publication Top Notes

Title: CAR T cells in solid tumors: challenges and opportunities
Year: 2021
Citations: 660

Title: Exosome engineering in cell therapy and drug delivery
Year: 2023
Citations: 250

Title: Recent advances in non-small cell lung cancer targeted therapy; an update review
Year: 2023
Citations: 228

Title: Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
Year: 2021
Citations: 202

Title: Th17 and Treg cells function in SARS‐CoV2 patients compared with healthy controls
Year: 2020
Citations: 184

Title: The effects of oxygen–ozone therapy on regulatory T‐cell responses in multiple sclerosis patients
Year: 2021
Citations: 171

Title: CAR-T cell combination therapy: the next revolution in cancer treatment
Year: 2022
Citations: 135

Title: Solid tumors challenges and new insights of CAR T cell engineering
Year: 2019
Citations: 122

Title: Immune cell hacking: challenges and clinical approaches to create smarter generations of chimeric antigen receptor T cells
Year: 2018
Citations: 93

Title: CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Year: 2023
Citations: 74

Title: Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2
Year: 2021
Citations: 74

Title: Chimeric antigen receptor-T cell therapy: Applications and challenges in treatment of allergy and asthma
Year: 2020
Citations: 73

Title: Programmable and multi-targeted CARs: a new breakthrough in cancer CAR-T cell therapy
Year: 2020
Citations: 61

Title: The outlook for diagnostic purposes of the 2019‐novel coronavirus disease
Year: 2020
Citations: 49

Title: Study of immunomodulatory effects of mesenchymal stem cell-derived exosomes in a mouse model of LPS induced systemic inflammation
Year: 2022
Citations: 41

Title: Pro-tumorigenic and Anti-tumorigenic Roles of Pro-inflammatory Cytokines in Cancer
Year: 2022
Citations: 40

Title: Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients
Year: 2020
Citations: 39

Title: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
Year: 2021
Citations: 38

Title: Mesenchymal stem cell-based therapy as a new therapeutic approach for acute inflammation
Year: 2023
Citations: 34

Title: Longevity and anti-aging effects of curcumin supplementation
Year: 2024
Citations: 33

Title: Recent advances in antibody‐based immunotherapy strategies for COVID‐19
Year: 2021
Citations: 33

Title: E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy
Year: 2021
Citations: 32

Title: IL-38 as an early predictor of the ischemic stroke prognosis
Year: 2021
Citations: 30

Title: Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2
Year: 2021
Citations: 30

Title: Immune-based therapy for COVID-19
Year: 2021
Citations: 26

Title: Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?
Year: 2024
Citations: 20

Title: Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function
Year: 2022
Citations: 16

Title: Epigenetic biomarkers in aging and longevity: Current and future application
Year: 2024
Citations: 15

Title: Cellular and biological factors involved in healing wounds and burns and treatment options in tissue engineering
Year: 2022
Citations: 15

Title: Handbook of cancer and immunology
Year: 2022
Citations: 15

Title: Artificial intelligence for prediction of metastasis risk and survival
Year: 2024
Citations: 11

Title: The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease
Year: 2023
Citations: 10

Title: CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies
Year: 2023
Citations: 9

Title: COVID-19: our current knowledge of epidemiology, pathology, therapeutic approaches, and diagnostic methods
Year: 2021
Citations: 9

Title: Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies
Year: 2025
Citations: 7

Title: Immunogenicity of COVID‐19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: a systematic review and meta‐analysis
Year: 2023
Citations: 7

Title: Recent innovative approaches to intensify the efficacy and safety of CAR-T cell therapy in cancers
Year: 2022
Citations: 6

Title: Glycolysis and Autoimmune Diseases: A Growing Relationship
Year: 2020
Citations: 6

Title: Harnessing immunotherapy for hepatocellular carcinoma: Principles and emerging promises
Year: 2025
Citations: 5

Title: Effect of genetic profiling on surgical decisions at hereditary colorectal cancer syndromes
Year: 2024
Citations: 5

Title: The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under in vitro conditions
Year: 2021
Citations: 3

Title: Harnessing the fundamental roles of vitamins: the potent anti-oxidants in longevity
Year: 2025
Citations: 2

Title: Peptides in breast cancer therapy: From mechanisms to emerging drug delivery and immunotherapy strategies
Year: 2025
Citations: 2

Title: Harnessing IL-27: challenges and potential in cancer immunotherapy
Year: 2025
Citations: 2

Title: Anti-aging natural supplements: the main players in promoting healthy lifespan
Year: 2024
Citations: 2

Title: The Assessment of Anti–SARS‐CoV‐2 Antibodies in Different Vaccine Platforms
Year: 2024
Citations: 2

Title: Immunity to tetanus vaccination in pregnant women in Zanjan province, northwest of Iran
Year: 2018
Citations: 2

Title: Applications of CRISPR-Cas9 in mitigating cellular senescence and age-related disease progression
Year: 2025
Citation: 1

Title: CCAT2 role in gastrointestinal cancer progression and metastasis
Year: 2025
Citation: 1

Title: Breaking barriers: CAR-NK cell therapy breakthroughs in female-related cancers
Year: 2025
Citation: 1

Title: DCLK1 in gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target
Year: 2025
Citation: 1

Title: Macrophage polarization in hepatocellular carcinoma: a lncRNA-centric perspective on tumor progression and metastasis
Year: 2025
Citation: 1

Title: Translating preclinical insights into clinical strategies: Targeting cancer stem cells and stemness in prostate cancer
Year: 2025
Citation: 1

Conclusion

In conclusion, Dr. Safa Tahmasebi represents an exceptional example of academic excellence, research innovation, and leadership in the field of medical immunology. With a strong educational foundation, extensive professional experience, and impactful research contributions in cancer immunotherapy, stem cell biology, and immune regulation, she has established herself as a promising scientist. Her awards and honors further demonstrate her commitment to excellence, while her diverse research skills highlight her ability to bridge theory and practice. Through her publications, lectures, and community involvement, she has already made significant contributions to science and society. With her vision for advancing immunological therapies and her ability to inspire and mentor others, she holds immense potential to continue making groundbreaking contributions and is highly deserving of recognition through prestigious research awards.

Geou-Yarh Liou | Biochemistry | Best Researcher Award

Assoc. Prof. Dr. Geou-Yarh Liou | Biochemistry | Best Researcher Award 

Clark Atlanta University, United States

Rajesh N. Udavant is an emerging researcher in agricultural entomology with expertise in plant–insect interactions, host plant resistance, functional genomics, transcriptomics, and RNAi-based pest management. Currently pursuing graduate research at the University of Georgia, he has contributed significantly through international collaborations, including impactful work at ICRISAT on genome-wide gene identification and RNAi applications. His academic record, combined with technical proficiency in molecular biology, bioinformatics, and insect behavioral assays, reflects a strong multidisciplinary foundation. Rajesh has published in reputed journals and authored book chapters, with his research gaining recognition through best presentation awards and fellowships. He actively engages in scientific communities, demonstrating leadership and commitment to advancing sustainable crop protection. With growing global research exposure and impactful contributions, he holds strong potential to shape future directions in entomological research and agricultural innovation.

Professional Profile

Google Scholar | Orcid Profile

Education

Rajesh N. Udavant has pursued a strong academic path in agricultural sciences with specialization in entomology. He earned his Bachelor of Science in Agricultural Sciences from the College of Agriculture, Pathri, under VNMKV, India, where he built a foundation in crop protection and integrated pest management. He then completed a Master of Science in Agricultural Entomology from VNMKV with a thesis focusing on resistance mechanisms in chickpea against Helicoverpa armigera, employing advanced biochemical and morphological analyses. His master’s program allowed him to integrate traditional agricultural knowledge with molecular-level techniques, providing him with a competitive edge in the field of pest resistance studies. Currently, Rajesh is engaged in graduate-level research at the University of Georgia, USA, where he is specializing in functional genomics, transcriptomics, and RNAi approaches in vegetable entomology.

Professional Experience

Rajesh has acquired diverse professional experience through his roles as Research Fellow and Graduate Research Assistant across leading institutions. At ICRISAT, India, he contributed to genome-wide identification and RNAi-based gene silencing studies in Fall armyworm, gaining hands-on expertise in molecular entomology and metabolomics. As Senior Research Fellow at the Plant Protection Division, ICAR-CICR, he focused on morphological resistance in cotton against bollworms, integrating biocontrol agents into IPM strategies. Currently, at the University of Georgia, Rajesh is actively involved in transcriptomic and metabolomic analyses to understand plant defense and insect resistance mechanisms, particularly in whitefly–tomato interactions. His professional experience reflects strong international collaborations, technical adaptability, and consistent contributions to advancing crop resilience research. These roles demonstrate his ability to bridge laboratory innovations with applied pest management solutions.

Research Interest

Rajesh’s research interests lie at the intersection of molecular biology, entomology, and sustainable agriculture. His core focus is on plant–insect interactions, exploring functional and comparative genomics, host plant resistance, and RNAi technology to develop novel pest management strategies. He is particularly interested in transcriptomic and metabolomic analyses to unravel complex defense responses in plants against major insect pests such as whiteflies, bollworms, and fall armyworms. Rajesh’s work seeks to identify and validate molecular targets that can enhance crop resistance to biotic stressors, thereby reducing dependency on chemical pesticides and promoting eco-friendly agricultural practices. His research aims to integrate cutting-edge genomic tools with traditional crop protection methods, contributing to the development of climate-resilient and sustainable farming systems that can meet global food security challenges.

Awards and Honors

Rajesh has been recognized for his academic and research contributions with several awards and fellowships that highlight his growing impact in agricultural sciences. He was honored with the Best Oral Presentation Award at the Entomology Student Conclave organized by the Entomological Society of India, reflecting his ability to communicate complex research effectively. He also received the Best Poster Award at the ICAATAS International Conference for innovative contributions in crop protection research. Additionally, he was awarded the prestigious Sharad Pawar Agriculture Innovation Fellowship for his outstanding performance and potential in agricultural research. These recognitions not only validate his research excellence but also highlight his commitment to advancing sustainable solutions in crop protection, strengthening his profile as a promising researcher in the global scientific community.

Research Skill

Rajesh possesses a wide range of technical and analytical skills spanning molecular biology, bioinformatics, entomology, and data analysis. His expertise includes RNA/DNA isolation, PCR, RT-qPCR, dsRNA synthesis, transcriptomic analysis, HPLC, UPLC-Q-TOF, and protein profiling. In bioinformatics, he is skilled in RNA-Seq data analysis, gene annotation, phylogenomics, synteny analysis, and metabolomics using platforms such as DESeq2, Galaxy, STRING, and MetaboAnalyst. He is proficient in programming languages like R, Python, and MATLAB, which he applies to statistical analysis and image processing. Additionally, he has practical skills in insect handling, rearing, and conducting behavioral assays with pests like whiteflies, bollworms, and Spodoptera. His strong technical repertoire, combined with global research exposure, positions him as a versatile researcher capable of addressing complex agricultural challenges through integrated and innovative approaches.

Publication Top Notes

Title: Reactive oxygen species in cancer
Authors: Liou G.-Y., Storz P.
Year: 2010
Citation: Liou G.-Y., Storz P. Reactive oxygen species in cancer. Free Radical Research, 44(5): 479–496. exaly.com

Title: EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
Authors: Ardito C. M., Grüner B. M., Takeuchi K. K., Lubeseder-Martellato C., Liou G.-Y., et al.
Year: 2012
Citation: Ardito C. M., Grüner B. M., Takeuchi K. K., Lubeseder-Martellato C., Liou G.-Y., et al. EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis. Cancer Cell, 22(3): 304–317. exaly.com

Title: Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-κB and MMPs
Authors: Liou G.-Y., Döppler H., Necela B., Krishna M., Crawford H. C., Raimondo M., Storz P.
Year: 2013
Citation: Liou G.-Y., Döppler H., Necela B., Krishna M., Crawford H. C., Raimondo M., Storz P. Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-κB and MMPs. Journal of Cell Biology, 202(3): 563–577. exaly.com

Title: Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions
Authors: Liou G.-Y., Döppler H., DelGiorno K. E., Zhang L., Leitges M., Crawford H. C., et al.
Year: 2016
Citation: Liou G.-Y., Döppler H., DelGiorno K. E., Zhang L., Leitges M., Crawford H. C., et al. Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions. Cell Reports, 14(10): 2325–2336. exaly.com

Title: Transcription Repressor Slug Promotes Carcinoma Invasion and Predicts Outcome of Patients with Lung Adenocarcinoma
Authors: Shih J. Y., Tsai M. F., Chang T. H., Chang Y. L., Yuan A., Yu C. J., Lin S. B., Liou G.-Y., et al.
Year: 2005
Citation: Shih J. Y., Tsai M. F., Chang T. H., Chang Y. L., Yuan A., Yu C. J., Lin S. B., Liou G.-Y., et al. Transcription Repressor Slug Promotes Carcinoma Invasion and Predicts Outcome of Patients with Lung Adenocarcinoma. Clinical Cancer Research, 11(22): 8070–8078. exaly.com

Title: Mutant KRAS–Induced Expression of ICAM-1 in Pancreatic Acinar Cells Causes Attraction of Macrophages to Expedite the Formation of Precancerous Lesions
Authors: Liou G.-Y., Döppler H., Necela B., Edenfield B., Zhang L., Dawson D. W., et al.
Year: 2015
Citation: Liou G.-Y., Döppler H., Necela B., Edenfield B., Zhang L., Dawson D. W., et al. Mutant KRAS–Induced Expression of ICAM-1 in Pancreatic Acinar Cells Causes Attraction of Macrophages to Expedite the Formation of Precancerous Lesions. Cancer Discovery, 5(1): 52–63. exaly.com

Title: The Presence of Interleukin-13 at Pancreatic ADM/PanIN Lesions Alters Macrophage Populations and Mediates Pancreatic Tumorigenesis
Authors: Liou G.-Y., Bastea L., Fleming A., Döppler H., Edenfield B. H., Dawson D. W., et al.
Year: 2017
Citation: Liou G.-Y., Bastea L., Fleming A., Döppler H., Edenfield B. H., Dawson D. W., et al. The Presence of Interleukin-13 at Pancreatic ADM/PanIN Lesions Alters Macrophage Populations and Mediates Pancreatic Tumorigenesis. Cell Reports, 19(7): 1322–1333. exaly.com

Title: CD133 as a regulator of cancer metastasis through the cancer stem cells
Authors: Liou G.-Y.
Year: 2019
Citation: Liou G.-Y. CD133 as a regulator of cancer metastasis through the cancer stem cells. International Journal of Biochemistry and Cell Biology, 106: 1–7. exaly.com

Title: Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasia
Authors: Liou G.-Y., Döppler H., Braun U. B., Panayiotou R., Scotti Buzhardt M., et al.
Year: 2015
Citation: Liou G.-Y., Döppler H., Braun U. B., Panayiotou R., Scotti Buzhardt M., et al. Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasia. Nature Communications, 6: 6200. exaly.com

Title: NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar–Ductal Transdifferentiation in the Pancreas
Authors: Chen N. M., Singh G., Koenig A., Liou G.-Y., Storz P., Zhang J. S., Regul L., et al.
Year: 2015
Citation: Chen N. M., Singh G., Koenig A., Liou G.-Y., Storz P., Zhang J. S., Regul L., et al. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar–Ductal Transdifferentiation in the Pancreas. Gastroenterology, 148(5): 1024–1034.e9. exaly.com

Title: Macrophage cytokines enhance cell proliferation of normal prostate epithelial cells through activation of ERK and Akt
Authors: Dang T., Liou G.-Y.
Year: 2018
Citation: Dang T., Liou G.-Y. Macrophage cytokines enhance cell proliferation of normal prostate epithelial cells through activation of ERK and Akt. Scientific Reports, 8: 7718. exaly.com

Title: Ym1+ macrophages orchestrate fibrosis, lesion growth, and progression during development of murine pancreatic cancer
Authors: Liou G.-Y., et al.
Year: 2022
Citation: Liou G.-Y., et al. Ym1+ macrophages orchestrate fibrosis, lesion growth, and progression during development of murine pancreatic cancer. iScience, 25: 104327. exaly.comDigital Library of Georgia

Title: Impact of immune cells in the tumor microenvironment of prostate cancer metastasis
Authors: Messex J. K., Liou G.-Y.
Year: 2023
Citation: Messex J. K., Liou G.-Y. Impact of immune cells in the tumor microenvironment of prostate cancer metastasis. Life, 13: 333. exaly.com

Title: Macrophages cytokine Spp1 increases growth of prostate intraepithelial neoplasia to promote prostate tumor progression
Authors: Messex J. K., Byrd C. J., Thomas M. U., Liou G.-Y.
Year: 2022
Citation: Messex J. K., Byrd C. J., Thomas M. U., Liou G.-Y. Macrophages cytokine Spp1 increases growth of prostate intraepithelial neoplasia to promote prostate tumor progression. International Journal of Molecular Sciences, 23: 4247. exaly.com

Title: Involvement of Reactive Oxygen Species in Prostate Cancer and Its Disparity in African Descendants
Authors: Liou G.-Y.
Year: 2024
Citation: Liou G.-Y. Involvement of Reactive Oxygen Species in Prostate Cancer and Its Disparity in African Descendants. International Journal of Molecular Sciences, 25: 6665. exaly.com

Title: Cytokine CCL9 Mediates Oncogenic KRAS-Induced Pancreatic Acinar-to-Ductal Metaplasia by Promoting Reactive Oxygen Species and Metalloproteinases
Authors: Byrd C., Liou G.-Y., Storz P., Messex J. K.
Year: 2024
Citation: Byrd C., Liou G.-Y., Storz P., Messex J. K. Cytokine CCL9 Mediates Oncogenic KRAS-Induced Pancreatic Acinar-to-Ductal Metaplasia by Promoting Reactive Oxygen Species and Metalloproteinases. International Journal of Molecular Sciences, 25: 4726. exaly.com

Conclusion

In summary, Rajesh N. Udavant embodies the qualities of a dedicated and impactful agricultural researcher with a strong academic foundation, diverse professional experiences, and innovative research contributions. His expertise in molecular entomology and sustainable pest management demonstrates both depth and breadth, aligning with pressing global agricultural needs. Recognized through multiple awards, fellowships, and international collaborations, he has proven his ability to excel in both research and scientific communication. His technical skills, combined with a clear vision for sustainable farming practices, reflect his potential to contribute significantly to global food security and crop resilience. Rajesh is not only deserving of recognition such as the Best Researcher Award but also holds the promise of becoming a future leader in agricultural sciences, bridging science, innovation, and community impact.

 

Dmitry Baytin | Biochemistry | Best Researcher Award

Dr. Dmitry Baytin | Biochemistry | Best Researcher Award

Senior Scientist at Peter the Great St. Petersburg Polytechnic University, Russia

Dr. Dmitry Baytin is a distinguished research scientist specializing in protein biochemistry, with a focus on RecA and SOS response proteins from various bacterial species. He holds a Ph.D. in biochemistry and a Doctor of Sciences degree, complemented by postdoctoral training in leading international laboratories. His expertise lies in DNA repair mechanisms, homologous recombination, and the molecular basis of antibiotic resistance, where he has made notable contributions through the development of innovative models and inhibitors targeting RecA activity. Dr. Baytin has authored more than 25 publications in high-impact journals, secured competitive research grants, and contributed to patented innovations. Currently serving as a senior researcher, he collaborates internationally, mentors young scientists, and advances fundamental discoveries with significant implications for combating antibiotic resistance and enhancing molecular biology research.

Professional Profile